“Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate with Different BCR-ABL Transcripts Levels Response”, MLU, vol. 21, no. 1, pp. 949–955, Jan. 2021, doi: 10.37506/mlu.v21i1.2438.